BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 31748823)

  • 1. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
    Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
    Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.
    Soloff EV; Zaheer A; Meier J; Zins M; Tamm EP
    Abdom Radiol (NY); 2018 Feb; 43(2):301-313. PubMed ID: 29198002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
    Garces-Descovich A; Beker K; Jaramillo-Cardoso A; James Moser A; Mortele KJ
    Abdom Radiol (NY); 2018 Feb; 43(2):314-322. PubMed ID: 29392370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
    Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
    Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
    Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
    Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma.
    Noda Y; Goshima S; Kawada H; Kawai N; Miyoshi T; Matsuo M; Bae KT
    AJR Am J Roentgenol; 2018 Jun; 210(6):1252-1258. PubMed ID: 29629801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
    Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
    Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
    Park SJ; Jang S; Han JK; Kim H; Kwon W; Jang JY; Lee KB; Kim H; Lee DH
    Eur Radiol; 2021 Sep; 31(9):6889-6897. PubMed ID: 33740095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma.
    Walters DM; Lapar DJ; de Lange EE; Sarti M; Stokes JB; Adams RB; Bauer TW
    Ann Surg Oncol; 2011 Oct; 18(10):2764-71. PubMed ID: 21484522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning.
    Zaky AM; Wolfgang CL; Weiss MJ; Javed AA; Fishman EK; Zaheer A
    Radiographics; 2017; 37(1):93-112. PubMed ID: 27885893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.
    Isaji S; Mizuno S; Windsor JA; Bassi C; Fernández-Del Castillo C; Hackert T; Hayasaki A; Katz MHG; Kim SW; Kishiwada M; Kitagawa H; Michalski CW; Wolfgang CL
    Pancreatology; 2018 Jan; 18(1):2-11. PubMed ID: 29191513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
    Shi S; Hua J; Liang C; Meng Q; Liang D; Xu J; Ni Q; Yu X
    Ann Surg; 2019 May; 269(5):944-950. PubMed ID: 29334560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
    Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
    Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined TNM-staging for pancreatic adenocarcinoma - Real progress or much ado about nothing?
    Roalsø M; Aunan JR; Søreide K
    Eur J Surg Oncol; 2020 Aug; 46(8):1554-1557. PubMed ID: 32107094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Friendly Summary of the ACR Appropriateness Criteria: Staging of Pancreatic Ductal Adenocarcinoma.
    Rybicki FJ; Lalani T
    J Am Coll Radiol; 2019 Apr; 16(4 Pt A):e15. PubMed ID: 30947954
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis.
    Kim JK; DePeralta DK; Ogami T; Denbo JW; Pimiento J; Hodul PJ; Malafa MP; Kim DW; Fleming JB; Powers BD
    J Surg Oncol; 2020 Nov; 122(6):1074-1083. PubMed ID: 32673436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.